Kassuhn, W.; Cutillas, P.R.; Kessler, M.; Sehouli, J.; Braicu, E.I.; Blüthgen, N.; Kulbe, H.
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients. Cancers 2023, 15, 3155.
https://doi.org/10.3390/cancers15123155
AMA Style
Kassuhn W, Cutillas PR, Kessler M, Sehouli J, Braicu EI, Blüthgen N, Kulbe H.
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients. Cancers. 2023; 15(12):3155.
https://doi.org/10.3390/cancers15123155
Chicago/Turabian Style
Kassuhn, Wanja, Pedro R. Cutillas, Mirjana Kessler, Jalid Sehouli, Elena I. Braicu, Nils Blüthgen, and Hagen Kulbe.
2023. "In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients" Cancers 15, no. 12: 3155.
https://doi.org/10.3390/cancers15123155
APA Style
Kassuhn, W., Cutillas, P. R., Kessler, M., Sehouli, J., Braicu, E. I., Blüthgen, N., & Kulbe, H.
(2023). In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients. Cancers, 15(12), 3155.
https://doi.org/10.3390/cancers15123155